Actinic Keratosis clinical trials

Explore recruiting actinic keratosis clinical trials.

Recruiting actinic keratosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Actinic Keratosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and Safety of Cryotherapy followed by Tirbanibulin ointment for actinic keratosis on the scalp and forehead

France

Phase III and phase IV (Integrated) EU CTIS Study details

Prospective, multistage, two-arm, randomised, double-blind study on the efficacy and safety of treatment of mild to moderate actinic keratosis with a 5% potassium hydroxide solution versus placebo with different duration of treatment cycles

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Clinical efficacy and safety of sequential therapy with cryotherapy and topical tirbanibulin 1% in actinic keratoses in transplant recipients: a randomised clinical trial.

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

An exploratory, multicenter, randomized, open-label with blind evaluation, active-controlled study to evaluate the safety and efficacy of Keramod® (imiquimod 50 mg/g, Gel) compared with Aldara® (imiquimod 50 mg/g, Cream) for the treatment of actinic keratosis in adults.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Combination therapy of 5-Fluorouracil and Calcipotriol versus 5-Fluorouracil in the treatment of Actinic Keratosis: a multicentre randomized controlled clinical trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE I TRIAL TO INVESTIGATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING TOPICAL DOSES OF GZ21T IN HEALTHY VOLUNTEERS

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

Actinic Keratosis trials by city

Actinic Keratosis in Toronto Actinic Keratosis in Vancouver Actinic Keratosis in Montreal Actinic Keratosis in Calgary Actinic Keratosis in Edmonton Actinic Keratosis in Ottawa Actinic Keratosis in Winnipeg Actinic Keratosis in Quebec City Actinic Keratosis in Hamilton Actinic Keratosis in Kitchener Actinic Keratosis in London Actinic Keratosis in Halifax Actinic Keratosis in New York Actinic Keratosis in Los Angeles Actinic Keratosis in Chicago Actinic Keratosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease